Business Description
Dar Al Dawa Development and Investment
ISIN : JO4101211012
Compare
Compare
Traded in other countries / regions
DADI.Jordan IPO Date
1978-01-01Description
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives of the company are to manufacture pharmaceutical, chemical, pharmaceutical, and related products and to import medicines. It offers products in the therapeutic areas of anti-infective, cardiovascular and diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.3 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 1.07 | |||||
| Debt-to-EBITDA | 5.51 | |||||
| Interest Coverage | 1.61 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 1.35 | |||||
| Beneish M-Score | -2.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.2 | |||||
| 3-Year EBITDA Growth Rate | -32.5 | |||||
| 3-Year EPS without NRI Growth Rate | 24.3 | |||||
| 3-Year FCF Growth Rate | 5.9 | |||||
| 3-Year Book Growth Rate | 1.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.13 | |||||
| 9-Day RSI | 50.16 | |||||
| 14-Day RSI | 49.6 | |||||
| 6-1 Month Momentum % | -2.31 | |||||
| 12-1 Month Momentum % | -4.51 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.14 | |||||
| Quick Ratio | 0.81 | |||||
| Cash Ratio | 0.21 | |||||
| Days Inventory | 172.43 | |||||
| Days Sales Outstanding | 148.47 | |||||
| Days Payable | 133.95 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -11.9 | |||||
| Shareholder Yield % | -2.41 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.38 | |||||
| Operating Margin % | 8.12 | |||||
| Net Margin % | 4.46 | |||||
| FCF Margin % | -2.64 | |||||
| ROE % | 7.26 | |||||
| ROA % | 2.92 | |||||
| ROIC % | 8.13 | |||||
| 3-Year ROIIC % | -73.59 | |||||
| ROC (Joel Greenblatt) % | 9.87 | |||||
| ROCE % | 13.56 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.3 | |||||
| PE Ratio without NRI | 13.3 | |||||
| Shiller PE Ratio | 124.11 | |||||
| PS Ratio | 0.58 | |||||
| PB Ratio | 0.91 | |||||
| Price-to-Tangible-Book | 0.99 | |||||
| Price-to-Operating-Cash-Flow | 104.17 | |||||
| EV-to-EBIT | 12.16 | |||||
| EV-to-EBITDA | 8.61 | |||||
| EV-to-Revenue | 1.07 | |||||
| EV-to-FCF | -40.59 | |||||
| Price-to-GF-Value | 0.9 | |||||
| Price-to-Projected-FCF | 0.85 | |||||
| Price-to-Median-PS-Value | 0.88 | |||||
| Price-to-Graham-Number | 0.77 | |||||
| Price-to-Net-Current-Asset-Value | 4.81 | |||||
| Earnings Yield (Greenblatt) % | 8.22 | |||||
| FCF Yield % | -4.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dar Al Dawa Development and Investment Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil JOD) | 75.074 | ||
| EPS (TTM) (JOD) | 0.094 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.04 | ||
| 3-Year Sortino Ratio | 0.09 | ||
| Volatility % | 5.79 | ||
| 14-Day RSI | 49.6 | ||
| 14-Day ATR (JOD) | 0.013966 | ||
| 20-Day SMA (JOD) | 1.2615 | ||
| 12-1 Month Momentum % | -4.51 | ||
| 52-Week Range (JOD) | 1.21 - 1.41 | ||
| Shares Outstanding (Mil) | 35 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dar Al Dawa Development and Investment Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dar Al Dawa Development and Investment Stock Events
| Event | Date | Price (JOD) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dar Al Dawa Development and Investment Frequently Asked Questions
What is Dar Al Dawa Development and Investment(AMM:DADI)'s stock price today?
The current price of AMM:DADI is JOD1.25. The 52 week high of AMM:DADI is JOD1.41 and 52 week low is JOD1.21.
When is next earnings date of Dar Al Dawa Development and Investment(AMM:DADI)?
The next earnings date of Dar Al Dawa Development and Investment(AMM:DADI) is .
Does Dar Al Dawa Development and Investment(AMM:DADI) pay dividends? If so, how much?
Dar Al Dawa Development and Investment(AMM:DADI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers